BHC:CC News and Press, Bausch Health Companies Inc. From 11/05/25

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL, QC / ACCESS Newswire / November 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutic...

2025-10-31 07:45:00 ET When Bausch Health Companies ( BHC ) posted third-quarter results, shares jumped to as high as almost $7.00 on the day. It ended up by 12.03% on October 30, up by 12.03%.... Read the full article on Seeking Alpha For further details see: Why Ba...

The S&P 500 fell on Thursday as investors digested a batch of Big Tech earnings, while a meeting between President Donald Trump and Chinese President Xi Jinping concluded. The Dow Jones Industrials index surged 215.54 points Thursday to 47,847.54 The broader dipped 21.91 points to 6,8...

2025-10-29 20:27:27 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health rises on 20...

2025-10-29 20:26:29 ET Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript

2025-10-29 17:53:11 ET More on Bausch Health Companies Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health Companies Q3 2025 Earnings Preview Bausch, Teva face lawsuit for delay in gener...

2025-10-29 16:37:19 ET More on Bausch Health Companies Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health Companies Q3 2025 Earnings Preview Bausch, Teva face lawsuit for delay in gener...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $179 million and GAAP Net Income of $181 million Consolidated Adjusted EBITDA Attribut...

Algoma Steel Group Inc. (ASTL:CA) is expected to report $-0.97 for Q3 2025 Timbercreek Financial Corp. (TF:CA) is expected to report $0.17 for Q3 2025 Canadian Pacific Kansas City Limited (CP:CA) is expected to report $1.13 for Q3 2025 Acadian Timber Corp. (ADN:CA) is expected to repo...

2025-10-10 17:18:54 ET Shares of biopharmaceutical concern Monopar Therapeutics Inc. ( MNPR ) have had an absolutely massive surge in the past year after being left for dead with cash of $7.1 million and a market cap under $9 million. Its acquisition of Wilson disease candidate ALXN-184...